19.47
-1.18(-5.71%)
Currency In USD
| Previous Close | 20.65 |
| Open | 20.51 |
| Day High | 20.84 |
| Day Low | 19.45 |
| 52-Week High | 27.64 |
| 52-Week Low | 19.46 |
| Volume | 646,900 |
| Average Volume | 834,193 |
| Market Cap | 840.94M |
| PE | 41.59 |
| EPS | 0.47 |
| Moving Average 50 Days | 24.32 |
| Moving Average 200 Days | 24.47 |
| Change | -1.1 |
If you invested $1000 in Pacira BioSciences, Inc. (PCRX) 10 years ago, it would be worth $293.41 as of January 16, 2026 at a share price of $19.547. Whereas If you bought $1000 worth of Pacira BioSciences, Inc. (PCRX) shares 5 years ago, it would be worth $264.69 as of January 16, 2026 at a share price of $19.547.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Pacira Announces Agreement with LG Chem to Make EXPAREL® Available in Select Asian-Pacific Markets
GlobeNewswire Inc.
Jan 13, 2026 1:00 PM GMT
-- LG Chem becomes exclusive distributor of EXPAREL -- – Partnership expands patient access to opioid-sparing pain control and advances 5x30 strategy– BRISBANE, Calif., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX), th
Pacira Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Revenues
GlobeNewswire Inc.
Jan 08, 2026 9:01 PM GMT
-- Record-high EXPAREL sales driven by volume growth of 7 percent, marking strongest fourth quarter performance in three years-- BRISBANE, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its
Pacira BioSciences to Present at the 44th Annual J.P. Morgan Healthcare Conferences
GlobeNewswire Inc.
Jan 07, 2026 1:00 PM GMT
BRISBANE, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that it will pre